Commitment to Corporate Social Entrepreneurship in the context of a health crisis. The case of the scientist-entrepreneur couple who founded BioNTech

If Corporate Social Responsibility calls for a virtuous process in which health for all becomes egalitarian, ethical and equitable, the health crisis (Covid-19) revealed certain limitations to this process.The aim of our research is to identify the limitations that can hinder Corporate Social Entrepreneurship' commitment of coentrepreneurs (founders of BioNTech) in the dissemination of "their" vaccine in the context of a health crisis. The difficulties encountered in disseminating the Comirnaty vaccine (Pfizer-BioNTech) in the African continent are exemplary in this respect. A literature review presents the concept of CSE (Corporate Social Entrepreneurship). We then present 2 research proposals: How can the CSE influence the CSR performance of copreneurs? What kinds of limitations may hinder CSE's commitment to success in a health crisis context? Concerning the research method, we use a qualitative approach with the investigation of a unique case study of the scientist-entrepreneur couple who founded BioNTech and led the Lightspeed project that gave birth to the Cominarty vaccine (Pfizer-BioNTech) during the health crisis. Concerning the results, CSE expands the scope of companies' activities and their organizational values, pushing them to rethink their current CSR approaches by combining team commitment, will and desire to create common economic and social values.